Heart failure

Scottish Health Purchasing Information Centre
Record ID 31998009126
English
Authors' objectives:

This report aims to answer the following questions:

1. Are ACE inhibitors now the treatment of choice in heart failure?

2. Should general practitioners have open access to echocardiography?

Authors' recommendations: 1. The ACE inhibitors are beneficial and cost-effective in most but not all causes of heart failure. 2. The cost of ACE inhibitors is falling. Their use in heart failure will be cost-saving if the resources saved in hospital are released for use in primary care. 3. Echocardiography is a valuable investigation and we recommend that general practitioners should have access to it. Ideally, this should be by a rapid cardiology consultation including echocardiography as part of a total assessment of heart failure. If this cannot be provided, an open access service providing an echocardiography interpretation is the second option, and can provide a useful triage system to reduce the workload of the cardiology service.
Authors' methods: Review
Details
Project Status: Completed
Year Published: 1998
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Scotland, United Kingdom
MeSH Terms
  • Angiotensin-Converting Enzyme Inhibitors
  • Costs and Cost Analysis
  • Echocardiography
  • Heart Diseases
Contact
Organisation Name: Scottish Health Purchasing Information Centre
Copyright: Scottish Health Purchasing Information Centre
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.